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In scleroderma (system.ic sclerosis, SSc), an autolln-
Dlune disorder in which excessive extracellular l11a-
trix is deposited in skin and internal organs, one of
the suggested contributory factors to the develop-
Dlent of fibrosis is a decrease in collagenase activity
that may be related to levels of serum tissue inhibi-
tors of metalloproteinases 1 (TIMP-l). We recently
reported that the serum TIMP-llevcls in SSc patients
were elevated cOlupared with nortnal controls. To
determine the biologic significance ofTIMP-l in SSc,
we compared the proliferative effects of TIMP-l be-
tween normal and SSc fibroblasts. TIMP-l showed
significant tnitogenic activity for both nortnal and
SSc fibroblasts. The mitogenic responses to TIMP-l
(33-100 ng/ml) in SSc fibroblasts, however, were sig-
nificantly greater than those in norn-lal controls and
I n scierodelTna (systemic sclerosis, SSc), developmcnt offibrosis is prominent in the skin and arious organs. IIIgeneral, tissuc fibrosis rclkcts. an imbalance betwcc.n colla-gcn productIOn and degradatloll. 1n scvcral studies, fibro-blasts grown (i'om SSc p"tiellts have revcaled illcreased
synthesis of collagcn (LeRoy 1974; Uitto el til, 1979: Fleischmajer
el til, 1981), Although collagcnase activity and collagen degradati II
have been reported to be normal in SSc fibroblasts (Uitto el til,
1 979), Takeda cl (/1 (1994) reported th"t SSc fibroblasts exhibitcd a
marked decrease in collagenase activity and production. Collagc-
nase activity is regulMed by various ellzymes alld cytokines (Caw-
stan, 1986). Tissue inhibitor of mctalloproteinase 1 (TIMP-'I) is
capable of inactivating collagenase activity. In accordance with this
finding, two groups have recently reporred enhanced exprcssion of
TIMP-l in sclerodcrma fibroblasts (B u-Ghalios ('I (/1, 1995; Kirk ('(
aI, 1995). Wc have also detected elcvatcd serum TlMP-1 concen-
trations in SSc patiems. suggesting the ovel'production ofTIMP-1
ill "i"o in these patients (Kikuchi el (/1, 1995b). Interesriugly,
TJMP-I has been shQ\ 11 to have mitogcnic activities 1'01' various
cell types including dermal fibroblasts (Hayakawa ('{ (/1, 1992).
Tflkcn together, th 'se obscrvations suggest that TIMP-l might be
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were conl.pletcly ncutralized ill the presence of anti-
TIMP-l IgG. Moreover, anti-TIMP-l IgG partially
but significantly blockcd the basal tnitogenic activi-
ties of SSc fibroblasts. SSc fibroblasts produced in-
creased alnounts of TIMP-l relative to nOrl1.1.al fibro-
blasts, as confinned by western blotting, ELISA, and
RT-peR teclul.iques. In contrast, transforming
growth factor {H (TGF-{H) upregulated TIMP-l pro-
duction lll. normal fibroblasts but not in SSc fibro-
blasts witll. c1evatcd spontaneous secretion of
TIMP-1. These observations suggest that TIMP-l
may play an inl.portant role as an autocrine growth
factor in the fibrotic proccss in SSc. Key "'O/'ds: sJ'sfelllic
sclel'osisltmllsforlllillg growtl' factor {3. J lI",est De,."ratol
108:281-284, 1997
involved not ouly in thc collagen accumulation but also in the
fibroblast proliferation in SSc. We invcstigated th> mitogenic
responses to TlMP-1 in Sc fibroblasts and their TIMP-I xprcs-
Slon.
MAT"R.IALS A D ~ETHOD
Cel.l Culture. SSc fibroblasts were obtained b)' skin hiopsy fi'om afleered
forcarll1 skin of seven fCI1I:1lc .I~pallc.sc pal;cnts ,,,ii'll difFuse cutalleous SSe
with less than a 2-, duration of skin thickening who fulfilled the American
1~l1cllnl;ltiSJI1 Association criteria for diagnosis (Anl "rican R.hctJI11:ltiSll1
Associarion. 1980). Conrrol norl1lal strains or fibroblasts (NS fibrohlasts)
wete obtaincd fra,n hcalthy donors matched with e:leh SSc patienr accord-
ing to sex, :1gc. and biopsy site and were processed ill parallel. The cell:,
were cultured in minimulll essential 111cdiu111 (MEM) supplemented with
10% fetal hovine serum (FIJS). ells at rhc third or fourl1, passage wcre used
for cxpcril11ClltS. Incubation was perfanned in T-75 flasks at 37° ill 95%1 air
~lId 5% 0,.
ll..cagcnts H...ccolnbinanr hlllU:l11 TI M P-I and lnol1oclol131 :ll1ti-hun\an
TIM 1'-1 I~G were purchased fr01l1 Fuji hcmic:l1 (Takaoka. J~pall). Re-
combill:lnr tralls(orl1lin~ ~rawth r.1elOr {31 (TGF-{3I) was purch:lsed 1"0111
I~ Ii..: 0 Systems ( ~illlle3p lis, MN).
Growth Assa)'s (r-'H)Th)'midine Incorporation Assa,") SSe and S
fihroblaSls (2 X 10" cells per well) werc pla'ed ill 2~-w II plares ill MEM
with 10'X, FilS alld growlI 1.0 cOllfluellc)'. The cells were washed wid,
phosphate-blln'creel s~lille ollce followed by :I 2·I-h illcuhariOIl ill M EM with
n.1 'Xl bovine Serulll rdbliltlin (scnlln-frc' 111Cdillll1; SFI\I\) .. The cells 'Wl:rc
rh'lI illcubated with various eOlleelllr:l,iolls orTIMp-1 in I'he presence or
:lbsence or:lllti-TIMP-I IgG for 2~ hill SFM. Ia"eled with 1.11 Irh)"lIIidille
(final concelltratioll I /-lCi/ml: New Ellgland uclear. 130stOIl, MA) for 2 h.
then w3shed three I imes with icc-cold phosphale-buncrcd s~line :llId fOl1r
tillies \vith SIXI rrichloroaccdc acid .. Fi,'c hundred l11icrolilcrs of O. I N
0022-202X/97/S 10.50' op)'ri~ht L 19')7 h)' The Societ)' (or In\lesti~ati\'e DermaLOlog)'. Inc.
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250
TIMP-l (ng/ml)
'x, Inhibition
100
72 ± II"
192:!:: 12
106 ± 6"
SSe (n = 4)
100
<)·1 :!:: 12
133 ± 12
lOS ± 5"
NS (n = 4)
SFM
anti-TIMI'-I IgG
TIMP-I (100 ng/ml)
TIMP-I + anti-TIMP-I Ig
Table 1. Auti-TIMP-l IgG Blocks the Mitogenic Activity
in Sclerodenna Fibroblasts"
<I COlIllUCll1 cells NS and SSe (ibrobl~~t~ were incuh<ltcd ill 'FM wilh Tll\lP-J (IOD
1I{:/rnl) anel ill 'he presellce or "h,ellce Ofallli-TIMP-I Il:G (1110 1"1. 1:50 dilurioll) for
2-1 h. Ccll'lO were laheled for 2 II wilh 1-'llJth),lIlidillc. E'lell cxpcrill1L'lll W;.IS performed
ill triplic:llC. IJH IThymidine incorpor:lI-iol1 (rpm) (l(thc cclb ill SFM wa'\ tlrhitrarily set
at 100'1':', ill cadl grotlp. E:H:h v~llIc rcprcllclHs the mC:1I1 :t SO or four cxpcril11c11ls.
I. Vnluc'\ sigltilic:1l1t1y ditfcrClIl frol1l (:orrcspolldillg values witlHlllt ilnti-TIlV1P-1 IgG
by the p'lircd Wil 'OXQll'S lcst; p < IL05.
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RESULTS
Figure 2. TIMJ'-l production is elevated in SSc fibrobl"sts, SSc or
NS fibroblasts (2 X I(r' cells per well) were se'ded ill 24-well plates in
M EM with ·10% lOllS and l;rowll to connucncy. alld tllen mediu.n was
replaced with SFM for 72 h. TIMP-I prodnctioll (nalll)gra1l1s per 2 X 10·
cells) was 1l1casured by enzyme-linked innnunosorbent assay in NS and SSc
fibroblasts. TIMI'-I production ill SSc libroblasts was significantly elevated
relalive to that in NS fibroblasts. E.rmr /)('1',1', SI (n = 7).
Mitogenic Response to TIMP-l in SSc Fibroblasts Is Ele-
vated Compared to NS Fibroblasts We fit'st investigated the
growth responses ofNS and SSc fibroblasts al the fourth passage to
v;lr.ious concentr"tions ofTJMP-'1 (3,3-1000 ng/ml). The mean ::!:
SD ofl-'l-rJthymidine incorporation (cpm) in the wcUs that receivcd
no reagcnt in the SFM only was 26'\ ± 32 cpm/wcll (mcan ± SD)
in NS fibroblasts and 278 ± 43 cpm/w ,II ill Sc fibroblasts, and thc
differcnce betwcen the two was not significlIlt. Thus, thc mcan
"00
30'0
-.;
oS
c
0
." 200u
::l
'0
e
c.
d.
"
100 Ii=
0
NS SSe
(11-7) (11:7)
Groups
lest, \Vilcoxon's paired resl. orStatistics \'Ve used Mann-\'Vhitnc)'
linear regression for statistical analyses.
in separate CXOIJ$ or at introll-CXol1 bOLll1d:lrics in LIte gellolllic sequence.
Tile RT-P It werc separated by agarose gel electrophorcsis and visualizcd
by lIsing erbidillll1 bromid' staining. Por quanriliC:llion, thc cI NA COncen-
tradon was firstnorlll,IIized by tile expression ofCi\DI'I-I. Two rnicrocllries
or dcoxycyddill ' 5' -triphosphate were Oldded ill the n.:acliol1 mixture, and
cDNA concentrations or different batches were compared. cDNA derived
rrom 150 ng orroral RNA waS prepared and dillited 1:2. 1:·1, I:8. I; 16. and
I ;32 in water. The peR products were elecLrophoresed ill a 21Ytl ;'lgarosc gel.
the 983-bp bands were excised. an I thc radioactivity incorporated into [he
DNA was nlCaSlIl'cd by eel' 'nkov ~cilllillalioll coul1ling. A standard curve
wa, dmwn fr01l1 rhe radioactivities and the relative ie"els or GAl PI-I gene
expre"ion were thus c:dculated. Similar expcriments werc perfonned by
using TIMP-I p,pilll 'rs to dcrenl1illc th' rcl::ltivc exprc~sjOI1 of the gene in
comparison with the corresponding GADI'H gene expression.
Figure 1. SSe fibroblasts sho\v il1creased Juitogcnic response to
TIMP-l compared with NS fibroblasts. Conflucnt SSe or NS fibroblasts
wcre slimulated with variou.~ concentrations orTIMP-1 for 24 h. TlMP-I
was addcd in 0.5 ml of serum-rree medium. and cells were labeled ror 2 h
with 1-'J-1Jthymidine. Each experimcnt was perrorlllcd in triplicate. 13J-1JThy-
midine incorporation (cprn) in the wells without TIMP-l was set at 100%
for each group. D. NS fibroblasts; •• SSc fibroblasts.·p 0.05 compared
to NS fibroblasts at the same concentration orTIMP-1 by Mann-Whitney
U test. Err",. b"rs, SD (n = 7).
NaOJ-l/O.I'X, sodiulll dode yl sulrate were added. and the radioactivit), waS
measurcd in 5 1111 or ACS II (Amersham. AriinglOn Heights, IL) with :1
liquid scintillation counter. All cxpCril1lCnlS were pcrfornlcd ill tripUcatc.
Measurement of TIMP-l Levels in Serum and Conditioned Me-
diu.lTI ""IMP-I concentration \vas dc.tcrt11illcd with a s:lnd"vich cnzynlc
inllllunoassay kit (Fuji hemicaJ IndustTies, Takaoka, Japan) that used two
kinds of monoclonal antibodies against hUlllan TIM 1'-1 (Kikuchi e/ "I.
1995a). SSc and NS tibroblasts (2 X 104 cells per well) were seeded in
24-well plates in MEM with 100;" FBS and grown to conflucncy. and then
mediulll was replaced with 0.5 ml or SFM followed by in 'ubation ror a
further 72 h. The conditioned medium was then collected and clarified by
centrifugation, and the cells remain;ng in the dishes were treated with
trypsin and coullred electrollically. TIMP-I concentration in the wells was
petermined as described above and collect·d by cell numbers per well.
Serum TI MP-1 levels in the SSc I atienes were detertnined as descI'ibed
(Kikuch; el ,,/, 1995a).
Western Blotting SS and NS fibroblasts (10" cells per dish) were
pia cd in l_cm2 dishes in MEM with 10% FilS and grown to conRuency,
and then medium was replaced with SFM and cells weI" incubated for 72 h.
The conditioned medium was then collected and clarified by centrifugation.
and the cells rCJll~linillg ill the dishes \,,,ere trealed \-\lith trypsin :lIld cOllllted
c1ectronicalJy. The conditioned medium fi'om SSc and NS fibroblasts was
concentrated 25-rold in an ultrafiltration device. The concenl rated samples
were normalized ror cell number and subjected to electrophoresis on
10-2()'Y" sodium dodecyl sulfate polyacrylamide gels. Proteins were elec-
trotransrerred rrom the gels OJ1tO nitrocellulose sheers. wbich were then
incubated with monoclonal anti-TIMI'-I IgG for 3 h. Pilrers wer then
incubated with alkaline phosphatase-conjngated goat anti-mouse IgG anti-
body (Capp'l. Durham, N ) for 1.5 h. and immunoreactive 51 ecies were
visualized with 5-bromo-4-cbloro-3-indolyl phosphaw (Sigma, St. Louis,
MO) and nicroblue tetrazoliuJl1 (Research Organics, Cleveland, 01-1).
Reverse Transcriptase-Coupled Polymerase Cbain Reactiou (PCR)
RT-P R was performed by using a GeneAmp RNA P rt kit (Perkin-
Elmer etus. orwalk. CT) according to the manufacturer's instructions.
BrieRy, total RNA from fibroblasts was isolated by the guanidium isothio-
cyanate method (Chomczynski and Sacchi, 1987). Aliquots or 1 l.Lg or total
RNA were rev'rse-transcribcd by using random hexam"r p,;mers. For
cDNA amplification. pCR was performed 1'01' 20 cycles. The cDNA
concentration was lirst Ilonnalized by the expression or glyceraldehyde-3-
phosphate dehydrogenase (GADPI-I). The primers used were 5'S primer,
nucleotides 71-96, and 3' AS pl·imer. nucleotides H)30-1053 (Arcari ci aI,
1984). which yielded a 983-bp product. Thc primer set based on the
published sequenccs of human TIMP-I cDNA was 5" primer. nucleotide5
94-J 14. and 3'AS primer. nucleotides 594 -614 (Docherty ('( ,II, ·1985). The
PCR product lorTIMP-1 w"s 520 bp. The primers were mRNA-specific in
that the recognition sites of the upstream and downstre,ml primers resided
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Figure 3. Serum TIMP-l level in each SSc patient is correlated
with the ill 11;1/'0 T1MP-l production of fibroblasts derived from the
same patient. Th· rc1:lLiollships belIYeell Spollt'll1eous T1Mp-I producrioll
(nanograms per 2 X 10" cells) by fibroblasts and serulll TIM P-I levels
(nanognulls per milliliter) ill seven SSc patieuts arC shown. r = 0.799; I' <
0.05 by lillear regressioll.
eI-!]thymidinc incorporation in the FM for each group was
arbitrarily set at '1 OO'X" and the efFects ofTIMP-1 were estimated as
a percentage ratio at each concentration. As shown in Fig 1, the
mitogenic response to exogenous TIMP-l became maximum when
the con entration ofTIMP-1 was 33 ng/ml in Sc (199 := --17%)
fibroblasts and 330 ng/ml i,n NS fibroblasts (135 := 31 %), respec-
tively. SS fibroblasts showed significantly greater mitogenic re-
sponses than NS fibroblasts when TIMP-'I was add'd at 33-100
ng/ml, suggesting that -c fibroblasts arc much more sensitive to
the mitogenic capabilit·y of TIM 1'-1 than NS fibroblasts. Allti-
TIMP-1 IgG (1:50 dilution) completely blocked the TIMP-l-
induced mitogenic response of both NS and SSc fibroblasts (Table
1). Moreover, anti-TIMP-1 TgG partially but significantl}' decreased
the basal mitogenic activity of SSc fibroblasts but not of NS
fibroblasts (Table I).
TIMP-l Expression Is Elevated in Scleroderma Fibroblasts
Because anti-TIMP-" IgG significanLly downregulated the sponta-
neous prolifel'ation of SSe fibroblasts, we assumed that these cells
may synth size and secrete high '1' amounts of TIMP-l rhan NS
fibroblasts. This was the ca 'e; SSc fibroblasts showed signi.ficantly
greater TTMP-1 production than NS fibroblasts as determined by
enzym '-linked il1lllll1nosorbent assay (59:!: 30 liS. 17 := 8 ng per
T1MP-l
520bp
G3POH
983bp
DI USSION
Figure 5: TIMl)-l mRNA expression is elevated in SSe fibroblasts.
Expression of TIMp-I IllJ'tNA in N alld SSe fibroblasl. was examined.
ml~NA WIIS amplified by reverse trllnscriptase-collpled pol)'lllerasc ellain
reaction using speci!'ic primers for GADPH (G3PDI-l) lind TIMP-I. Thc
predicted sizes for the all1plitication products were as follows: G OPH,983
bp; TIM 1'-1.520 bp. M. size marker (c/,x I74/HI/l'111 digcst) was included in
the cthjdilllll bromide agarose gel.
TIMp-I is a sialoglycoprot'in with a molecular mass of 28.5 kDa
that inhibits matrix metalloproteinases such as interstitial collage-
nase, gelatinase, and strome lysin. all of which -an degrade compo-
nents of the extracellular matri-'\: (Cawston, 1986). TIMP- 1 is
produced by many conne tive tis ue cells, \\'hich also produce
marrix metalloproteinases. Imbalance in the aCliviries of Illerallo-
proteinases and TIMP-I might be important in many pathologic
2 X 10" cells, p < 0.005: Fig. 2). The mean TIMp-1 production
was 3.5-fold higher in SSc fibroblast. than in fibroblasts. erum
TIMP-l level in each SSc patient was significantly correia red with
the ;1/ ,/;Iro TrMP-l production of fibroblasts derived fi-om the same
patient (1' = 0.799, I' < 0.05 by lineal' regression, Fig. 3). The
elevated I roduction ofTIMp-l in SSc fibroblasts was confirmed by
western blotting (Fig 4). Three strain of SS . fibroblasts exhibited
4.3-fold more TIMP-I production than NS fibroblasts as deter-
mined by densitometrica! analysis.
Furthermore. rlT-PCR reveal d the augmented gene expression
of TIMP-I in S c fibroblasts (Fig 5). The TIMP-I mR A
expression level in Sc fibroblasts was 5.6-fold higher than that of
S fibrol lasts as detected semiquanritatively. ince TGF-f3l is
known to upl'egulate the expression of TIM 1'-1. we finally in es-
tigated the effects ofTGF-,B1 in TIMp-l production ofS c and S
fibroblasts. In the pre 'nce of TGF-f31 at I ng/ml, TIMP-l
production was si!,'n.i.ficanrly increased in NS fibroblasts. whereas
no significant increase was obs'rved in c fibroblasts (Table II).
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Table n. Effects of TGF-131 011 TIMP-l Production in
Fibroblast Cultures"
TIM P-I Production
28--
KD
Reagent S (n = 4) SSe (n = 4)
o addition
TGF-{31 (I ng/ml)
17 :':: S
42:':: 16"
59:':: 30
63 :':: 31
Figure 4. T1MP-I overproduction iu SSe fibroblasts is revealed by
western blotting. The condilioned medinm of SSc or NS fibroblasts
cultures was subject'd to electrophoresis on 10-20°1., gradient polyacryl-
amide gels and a'J:Jiyzed b)' westel'll blottillg.
,I SSe and S librobl:t!ot~ (2 X 1().I cell, per well) were ~ccd(>d in l-1-\\"cll pl.HcS in
r..,\EM with 10% FGS :lIld grown to cuntlllcl1cy. :lnd lhen mcdium W:l\ rcp1:'lct..-d wilh
SFM followcd by incul>nlion (or 72 hill lhc prcscnce Of :lbllcncc nfTGF-1l1 (1 l1!:/ml).
TIMP-I produclion (n:lIlOhrrams per 2 X 10·' cells) W:lS mc.l1\urcd by cllzYl11c-linl"co
i1111llUIlU. OrhCl1l :ISO\:l)" ill N ;"Iud SSe fihrohlobts. E.1ch \'.1I11C rcprclil'lllS dll~ 111(':111 ..!: oSl).
II VallI '5 sigllitiC.1l\dy grcnler than NS lihrohla1\t1\ ill lhe ahsl'ncc ofTGF-/31 hy tin'
paired \Vi!coxol1's test; p < 0.05.
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conditions associated with excess deposition of extracellular matrix
such as liver cirrhosis, rheumatoid arthritis, and SSc. A recent study
demonstrated that human TIMP-1 has potent growth-promoting
activity in a wide range of human cells including fibroblasts
(Hayakawa eI ai, 1992). There have been several reports showing
elevated mitogenic activity in the sera of SSc patients for dermal
fibroblasts (LeRoy et ai, 1983; Potter el ai, 1984). In our previous
study, the mitogenic effects of sera derived from SSc patients were
partially but signifIcantly blocked by anti-TlMP-1 IgG (Kikuchi et
ai, 1995b). In this study, we showed the signific.mtly increased
mitogenic response to J·ecombinant TIMP-1 in SSc fibroblasts
rehltive to that in NS fibroblasts. The observation that anti-TIMP-1
IgG blocked the basal mitogenic activity in SSc fibroblasts suggests
an amocrine growth mechanism by TIMP-1. In keeping with this
finding, we also confirmed that the TIMP-l synthesis in SSc
fibroblasts was significantly elevated at both mRNA and protein
Icvels. We p"eviously reported that serum TIMP-l level in SSc
patients reAected their disease scverity (Kikuchi el a/ J 995b). It is
also interesting that serum TIMP-1 level in SSc patient was
correlated with the il/ /lillO TlMP-1 production offibroblasts derived
fi'om the patients. Unemori el 01 (1990) reported that TlMP was
secreted in both apical and basal directions by endothelial cells,
whereas colJagen, fibronectin, and several matrix-degrading met-
alloproteinases were secI·eted selectively in the basal direction. The
apically directed TIMP could account for the relatively high
concentration of serum TIM P, especially when overproduction of
TIMP occurs by fibmblasts.
The molecular basis underlying our finding ofincreased TlMP-1
level in SSc fibrob.lasts is not yet known. The cytok.ines TGF-{.3
(Overall ('I ai, 1991), tumor necmsis factor a (Chua et al,1990),
interleukin "] (Murphy el ai, 1985), and interleuk.in 6 (Lotz and
Guerne, 1991) ,Ire potent inducers of TIMP-1. All these factors,
especially TGF-{.3, are considered to be important in the pathogen-
esis of fibrotic diseases such as SSc. FOJ' example, there have becn
some reports that TGF-{.3 expression is increased in SSc lesions,
especially in the earlicr stages (Gruschwitz et ai, 1990; Gabrielli et ai,
1993; Higley et ai, 1994). We have previously reported that the
increased mitogenic response to TGF-{.31 in SSc fibroblasts is
mcdiated by another growth factor, connective tissue growth factor
(Kikuchi el ai, 1995a). The signal transduction mechanism respon-
sible for the growth promoting activ.ity ofTlMP-1 is still unknown,
but induction of another cytok.ine in fibroblasts may mediate this
growth activity. It should be mentioned that TGF-{.3 upregulated
the TIMV-l production only iJl NS but not in the SSc fibroblasts.
The hyporesponsiveness ofSSc fibroblasts to TGF-{.3 may rcAect the
early exposure to TGF-{.3 ill I/illo. Thus, the current results empha-
size the importance of TIMP-l expression in the pathogenesis of
SSc, suggesting that thc elevated production of TIMP-l may
contribute to thc autocrinc prolifcration of fibroblasts and excess
accumulation ofcollagen that ultimately leads to tissue fibrosis. Our
results suggest that an alltocrine mechanism involving TIMP might
bc important in fibrotic diseases.
This !/lori, is parlly ."'pported by a sralll}". srlr'rodemU/jimll IheJapallese /H;lIisll)'
'!I'Pllhl;c WI'I/are alld II gralll FilII/ Ilrl' Searl,' Sc:iCIII!fir FOlllldali",/.
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